Eastman Chemical Company filings document regulatory disclosures for a global specialty materials issuer with publicly traded common stock and outstanding debt securities. Form 8-K reports furnish quarterly and annual operating results, including sales, EBIT, cash flow, segment performance, price-cost conditions, raw-material pressures and updates tied to specialty businesses and methanolysis assets.
Proxy materials describe director elections, board committee matters, executive compensation, say-on-pay voting and shareholder proposals. Other material-event filings record debt issuance under registration statements and indentures, officer and director changes, compensatory arrangements, common stock references and note terms, including interest, maturity and redemption provisions.
Eastman Chemical Co. director Kim Ann Mink acquired 480 Phantom Stock Units on October 7, 2026, through an automatic deferral of part of her annual retainer that otherwise would have been paid in cash. Each unit has a value equal to the market value of one common share and is payable only in cash after termination of director service. Her reported resulting balance was 18,409 Phantom Stock Units.
Eastman Chemical Co. director James J. /ky Obrien acquired 480 Phantom Stock Units on October 7, 2026, through automatic deferral of a portion of annual retainer fees. Each unit has a value equal to the market value of one Eastman common share and is payable only in cash after termination of service as a director. The reported post-transaction balance was 19,159 units, including units credited since April 8, 2026, through dividend-equivalent reinvestment.
Humberto P. Alfonso reported acquisition or exercise transactions in this Form 4 filing. Eastman Chemical Co. (EMN) director Humberto P. Alfonso was credited with 1,162 Phantom Stock Units on October 7, 2026, at a reported value of $63.25 per unit through voluntary deferral of retainer fees otherwise payable in cash; those units include reinvested dividend equivalents. He was also credited with 480 units through automatic deferral of a portion of his annual retainer, including dividend-equivalent credits made since April 8, 2026.
Eastman Chemical Co. director Renee J. Hornbaker acquired 480 Phantom Stock Units on October 7, 2026, through automatic deferral of a portion of her annual retainer that otherwise would have been paid in cash. Each unit equals the market value of one Eastman common share and is payable only in cash after termination of service as a director. Her reported resulting balance was 53,088 Phantom Stock Units.
EASTMAN CHEMICAL CO (EMN) director James J. O'Brien reported several gift transfers of common stock on September 2, 2026. He made bona fide gifts of 5,378 shares held directly and 2,482 shares held indirectly through a revocable trust, and an associated family trust is reported as receiving 7,860 shares. After these transactions, he holds 1,628 shares directly and 7,860 shares indirectly through the O'Brien Family Dynasty Trust. No transactions are reported under a Rule 10b5-1 trading plan.
Eastman Chemical Company senior vice president and chief human resources officer Adrian James Holt reported selling 3,283 shares of common stock on August 4, 2026 at $71.31 per share in a sale described as an open market or private transaction, leaving 0 directly held common shares reported after the sale.
Eastman Chemical Company insider Adrian J. Holt filed a notice of proposed sales of common stock. The planned sale covers 3,283 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated value of $234,116.64. These shares are linked to restricted stock vesting on June 1, 2026 as compensation from the issuer. The notice also reports that during the prior three months, Holt sold 1,709 shares of common stock on May 5, 2026 for $131,678.45.
Eastman Chemical reported stronger quarterly results for the period ended June 30, 2026. Second quarter sales were $2,513 million, up from $2,287 million, driven by higher volume/product mix and higher prices, particularly in Advanced Materials and Chemical Intermediates, partly offset by lower Fibers volume. Gross profit rose to $560 million, and EBIT increased to $311 million from $222 million. Net earnings attributable to Eastman were $183 million with diluted EPS of $1.59 versus $1.20 a year earlier; adjusted EPS was $1.97 versus $1.60, helped by lower environmental and restructuring charges and benefits from IEEPA tariff refunds.
For the first six months, sales were $4,690 million versus $4,577 million, but EBIT declined to $499 million from $524 million and net earnings attributable to Eastman fell to $290 million from $322 million; adjusted EPS was $3.06, down from $3.51. Segment performance was mixed: Chemical Intermediates moved from a loss to positive Adjusted EBIT, Advanced Materials and Fibers delivered lower EBIT despite higher or stable sales, and Additives & Functional Products was broadly steady.
Cash from operating activities for the first six months was $87 million, modestly above the prior-year $66 million, as working capital absorbed cash. Capital expenditures were $203 million. Total borrowings were $5,217 million and cash and cash equivalents $691 million at June 30, 2026, with a fully undrawn $1.50 billion revolving credit facility. Environmental reserves totaled $321 million, with remediation spending expected over about 30 years. Common shares outstanding were 114,377,421 at June 30, 2026.
Eastman Chemical Company reported second-quarter 2026 sales revenue of $2,513 million, up 10 percent from $2,287 million a year earlier, driven by 5 percent higher volume/mix, 4 percent higher selling prices and a 1 percent favorable currency impact. EBIT was $311 million versus $222 million, and adjusted EBIT was $320 million versus $275 million. Diluted EPS was $1.59 versus $1.20, with adjusted EPS of $1.97 versus $1.60.
Advanced Materials and Additives & Functional Products each grew sales 5 percent, while Chemical Intermediates sales rose 39 percent and Fibers declined 11 percent. Segment EBIT improved sharply in Chemical Intermediates but decreased in Advanced Materials and Fibers. Net cash provided by operating activities was $224 million versus $233 million, and the company returned $96 million to stockholders through dividends. Net debt was $4,526 million at June 30, 2026.
Management highlighted progress toward $125 million to $150 million of cost savings, net of inflation, and expects 2026 capital expenditures of about $400 million. For 2026, operating cash flow is expected to approach $900 million, modestly below the previous outlook, and third-quarter adjusted EPS is projected to approach second-quarter 2026 adjusted EPS of $1.97.
Eastman Chemical Company senior vice president and chief human resources officer Adrian James Holt reported routine equity compensation activity involving restricted stock units. On June 1, 2026, 4,341 restricted stock units granted on June 1, 2023 vested and were settled into an equal number of common shares. To cover tax obligations on this vesting, 1,058 common shares were withheld rather than sold in the open market. After these transactions, Holt directly holds 3,283 shares of Eastman Chemical common stock, and the vested restricted stock unit award has been fully converted into shares.